Karl-Heinz Wiesmüller is CEO and co-founder of EMC microcollections GmbH. He has more than 20 years experience in combinatorial chemistry, expertise in peptide and lipopeptide synthesis and in synthetic vaccine development and immunochemistry documented in more than 170 original publications in peer-reviewed journals. Prior to his assignment at EMC he was Head of Libraries and Screening at EVOTEC BioSystems GmbH, Hamburg, and Leader of the Department of Biochemistry at the Natural & Medical Science Institute in Reutlingen. He holds a Habilitation degree in biochemistry, and doctoral degree (Dr. rer. Nat.) from the University of Tübingen where he is currently teaching as Professor of Biochemistry.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Acousia Therapeutics | CEO and Co-founder | — | — | Detail |